SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
BRNS

Barinthus Biotherapeutics plc. (NASDAQ:BRNS)

US · Delayed Price · Currency is USD
Also listed: VACCHealthcare · Biotechnology
$0.74-$0.02 (-2.49%)
 
Market cap
$30.2M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 30, 2021
Market Cap$30.23M-51.0%
Revenue (ttm)$0-100.0%
Net Income-$41.74M+39.9%
EPS-$1.03+40.5%
Shares Out40.85M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume376,145
Open$0.70
Previous Close$0.76
Day's Range$0.66 - $0.76
52-Week Range$0.51 - $1.83
Betan/a
AnalystsBuy
Price Target$3.00(+305.35%)
Earnings Daten/a
No price history available.

About BRNS

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases. The company is prioritizing the development of its proprietary SNAP-TI platform, designed to promote immune tolerance, with its lead candidate VTP-1000 targeting celiac disease. It is also developing VTP-300 for chronic hepatitis B using viral vector platform technologies, aimed at inducing disease-specific immune responses.

Address
20400 Century Boulevard, Germantown, MD, 20874, US
Market Cap
30 million
Employees
14
Industrial Classification
Biotechnology
Financial Health Score
Sound
From BRNS’s reported statements · Q2 2026 (trailing 12 months) · 4 of 5 pillars
1 Day
+0.00%
5 Days
+0.00%
1 Month
+0.01%
6 Months
+25.61%
1 Year
-50.99%

$BRNS stock is featured in our Insider Trades datasets.

→ All Stock Lists

Recently reported changes in BRNS holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by BRNS's directors and management

Net Shares Purchased by Insiders−1−102025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

BRNS Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New BRNS patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to BRNS from public contracts

Source: USAspending.gov

Bull Case vs Bear Case

AI-generated from BRNS’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
No data yet
—
Analyst Ratings
100% of score
60
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
0
Sells
0
Buy Value
$0
Distinct Buyers
0

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.